|
1
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu Y, Yang Y, Zhang C, Huang F, Wang F,
Yuan J, Wang Z, Li J, Li J, Feng C, et al: Clinical and biochemical
indexes from 2019-nCoV infected patients linked to viral loads and
lung injury. Sci China Life Sci. 63:364–374. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang
H, Xiong Y, Cheng Z, Gao S, Liang K, et al: Clinical
characteristics of refractory COVID-19 pneumonia in Wuhan, China.
Clin Infect Dis. Mar 16–2020.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qian GQ, Yang NB, Ding F, Ma AHY, Wang ZY,
Shen YF, Shi CW, Lian X, Chu JG, Chen L, et al: Epidemiologic and
clinical characteristics of 91 hospitalized patients with COVID-19
in Zhejiang, China: A retrospective, multi-centre case series. QJM.
Mar 17–2020.Epub ahead of print. View Article : Google Scholar
|
|
5
|
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao
Y, Xie C, Ma K, Shang K, Wang W and Tian DS: Dysregulation of
immune response in patients with COVID-19 in Wuhan, China. Clin
Infect Dis. Mar 12–2020.Epub ahead of print.
|
|
6
|
Tian S, Hu N, Lou J, Chen K, Kang X, Xiang
Z, Chen H, Wang D, Liu N, Liu D, et al: Characteristics of COVID-19
infection in Beijing. J Infect. 80:401–406. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han H, Ma Q, Li C, Liu R, Zhao L, Wang W,
Zhang P, Liu X, Gao G, Liu F, et al: Profiling serum cytokines in
COVID-19 patients reveals IL-6 and IL-10 are disease severity
predictors. Emerg Microbes Infect. 9:1123–1130. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yun H, Sun Z, Wu J, Tang A, Hu M and Xiang
Z: Laboratory data analysis of novel coronavirus (COVID-19)
screening in 2510 patients. Clin Chim Acta. 507:94–97. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Medetalibeyoğlu A, Şenkal N, Çapar G, Köse
M and Tükek T: Characteristics of the initial patients hospitalized
for COVID-19: A single-center report. Turk J Med Sci. Jun
3–2020.Epub ahead of print.
|
|
10
|
Guo T, Shen Q, Guo W, He W, Li J, Zhang Y,
Wang Y, Zhou Z, Deng D, Ouyang X, et al: Clinical characteristics
of elderly patients with COVID-19 in Hunan province, China: A
multi-center, retrospective study. Gerontology. May 29–2020.Epub
ahead of print. View Article : Google Scholar
|
|
11
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI
|
|
12
|
Petrakis D, Margină D, Tsarouhas K, Tekos
F, Stan M, Nikitovic D, Kouretas D, Spandidos DA and Tsatsakis A:
Obesity a risk factor for increased COVID-19 prevalence, severity
and lethality (Review). Mol Med Rep. 22:9–19. 2020.PubMed/NCBI
|
|
13
|
Castle SC, Uyemura K, Rafi A, Akande O and
Makinodan T: Comorbidity is a better predictor of impaired immunity
than chronological age in older adults. J Am Geriatr Soc.
53:1565–1569. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Castle SC, Uyemura K, Fulop T and
Makinodan T: Host resistance and immune responses in advanced age.
Clinics Geriatric Med. 23:463–479. 2007. View Article : Google Scholar
|
|
15
|
Nitulescu GM, Paunescu H, Moschos SA,
Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK,
Drakoulis N and Tsatsakis A: Comprehensive analysis of drugs to
treat SARS CoV 2 infection: Mechanistic insights into current
COVID-19 therapies (Review). Int J Mol Med. 46:467–488. 2020.
|
|
16
|
Stancioiu F, Papadakis GZ, Kteniadakis S,
Izotov BN, Coleman MD, Spandidos DA and Tsatsakis A: A dissection
of SARS-CoV2 with clinical implications (Review). Int J Mol Med.
46:489–508. 2020.
|
|
17
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.
|
|
18
|
Huisman W, Martina BEE, Rimmelzwaan GF,
Gruters RA and Osterhaus ADME: Vaccine-induced enhancement of viral
infections. Vaccine. 27:505–512. 2009. View Article : Google Scholar
|
|
19
|
Taylor A, Foo S-S, Bruzzone R, Dinh LV,
King NJC and Mahalingam S: Fc receptors in antibody-dependent
enhancement of viral infections. Immunol Rev. 268:340–364. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wolff GG: Influenza vaccination and
respiratory virus interference among Department of Defense
personnel during the 2017-2018 influenza season. Vaccine.
38:350–354. 2020. View Article : Google Scholar
|
|
21
|
Cowling BJ, Fang VJ, Nishiura H, Chan KH,
Ng S, Ip DK, Chiu SS, Leung GM and Peiris JS: Increased risk of
noninfluenza respiratory virus infections associated with receipt
of inactivated influenza vaccine. Clin Infect Dis. 54:1778–1783.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Skowronski DM, Sabaiduc S, Leir S, Rose C,
Zou M, Murti M, Dickinson JA, Olsha R, Gubbay JB, Croxen MA, et al:
Paradoxical clade- and age-specific vaccine effectiveness during
the 2018/19 influenza A(H3N2) epidemic in Canada: potential
imprint-regulated effect of vaccine (I-REV). Euro Surveill.
24:19005852019. View Article : Google Scholar :
|
|
23
|
Kelvin AA and Zambon M: Influenza
imprinting in childhood and the influence on vaccine response later
in life. Euro Surveill. 24:19007202019. View Article : Google Scholar :
|
|
24
|
Benn CS, Netea MG, Selin LK and Aaby P: A
small jab - a big effect: Nonspecific immunomodulation by vaccines.
Trends Immunol. 34:431–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rakebrandt N and Joller N: Infection
history determines susceptibility to unrelated diseases. BioEssays.
41:e18001912019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Demars A, Lison A, Machelart A, Van Vyve
M, Potemberg G, Vanderwinden JM, De Bolle X, Letesson JJ and
Muraille E: Route of infection strongly impacts the host-pathogen
relationship. Front Immunol. 10:15892019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pascual DW, Yang X, Wang H, Goodwin Z,
Hoffman C and Clapp B: Alternative strategies for vaccination to
brucellosis. Microbes Infect. 20:599–605. 2018. View Article : Google Scholar :
|
|
28
|
Kostoff RN, Goumenou M and Tsatsakis A:
The role of toxic stimuli combinations in determining safe exposure
limits. Toxicol Rep. 5:1169–1172. 2018. View Article : Google Scholar
|
|
29
|
Tsatsakis A, Petrakis D, Nikolouzakis TK,
Docea AO, Calina D, Vinceti M, Goumenou M, Kostoff RN, Mamoulakis
C, Aschner M and Hernández AF: COVID-19, an opportunity to
reevaluate the correlation between long-term effects of
anthropogenic pollutants on viral epidemic/pandemic events and
prevalence. Food Chem Toxicol. 141:1114182020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iddir M, Brito A, Dingeo G, Fernandez Del
Campo SS, Samouda H, La Frano MR and Bohn T: Strengthening the
immune system and reducing inflammation and oxidative stress
through diet and nutrition: Considerations during the COVID-19
Crisis. Nutrients. 12:122020. View Article : Google Scholar
|
|
31
|
Nilashi M, Samad S, Yusuf SYM and Akbari
E: Can complementary and alternative medicines be beneficial in the
treatment of COVID-19 through improving immune system function? J
Infect Public Health. 13:893–896. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cunningham-Rundles S, McNeeley DF and Moon
A: Mechanisms of nutrient modulation of the immune response. J
Allergy Clin Immunol. 115:1119–1128; quiz 1129. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mainardi T, Kapoor S and Bielory L:
Complementary and alternative medicine: Herbs, phytochemicals and
vitamins and their immunologic effects. J Allergy Clin Immunol.
123:283–294; quiz 295-296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jahns L, Conrad Z, Johnson LK, Whigham LD,
Wu D and Claycombe-Larson KJ: A diet high in carotenoid-rich
vegetables and fruits favorably impacts inflammation status by
increasing plasma concentrations of IFN-α2 and decreasing MIP-1β
and TNF-α in healthy individuals during a controlled feeding trial.
Nutr Res. 52:98–104. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Majde JA and Krueger JM: Links between the
innate immune system and sleep. J Allergy Clin Immunol.
116:1188–1198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chandra RK: Nutrition, immunity and
infection: From basic knowledge of dietary manipulation of immune
responses to practical application of ameliorating suffering and
improving survival. Proc Natl Acad Sci USA. 93:14304–14307. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Briguglio M, Pregliasco FE, Lombardi G,
Perazzo P and Banfi G: The malnutritional status of the host as a
virulence factor for new coronavirus SARS-CoV-2. Front Med
(Lausanne). 7:1462020.
|
|
38
|
Marcos A, Nova E and Montero A: Changes in
the immune system are conditioned by nutrition. Eur J Clin Nutr.
57(Suppl 1): S66–S69. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Langley-Evans SC and Carrington LJ: Diet
and the developing immune system. Lupus. 15:746–752. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang H, Sun Y, Cai R, Chen Y and Gu B: The
impact of dietary fiber and probiotics in infectious diseases.
Microb Pathog. 140:1039312020. View Article : Google Scholar
|
|
41
|
Saeed F, Nadeem M, Ahmed RS, Nadeem MT,
Arshad MS and Ullah A: Studying the impact of nutritional
immunology underlying the modulation of immune responses by
nutritional compounds - a review. Food Agric Immunol. 27:205–229.
2016. View Article : Google Scholar
|
|
42
|
Davison G, Kehaya C and Wyn Jones A:
Nutritional and physical activity interventions to improve
immunity. Am J Lifestyle Med. 10:152–169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Skalny AV, Rink L, Ajsuvakova OP, Aschner
M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos
DA, Aaseth J, et al: Zinc and respiratory tract infections:
Perspectives for COVID-19 (Review). Int J Mol Med. 46:17–26.
2020.
|
